Is bmiMD Legit? The Honest 2026 Review

Yes. bmiMD is a legitimate US telehealth weight-loss provider. It holds a verified 4.4/5 rating from 869 Trustpilot reviews on a profile the company claimed in April 2024, reports more than 80,000 members, and connects patients with licensed clinicians who prescribe compounded semaglutide and tirzepatide dispensed by compounding pharmacies. We searched the FDA's public warning-letter database in August 2026 and found no letter naming bmiMD. As with every compounded provider, the medication itself is not an FDA-approved finished product.

bmiMD charges $119/month for compounded semaglutide and $179/month for compounded tirzepatide on its 12-month best-value plan. Month-to-month runs higher at $159 and $249 respectively. Telehealth visits, medication and shipping are included in that price, and there is no separate membership fee. That makes it the #6 cheapest semaglutide option among the 19 providers we track, against a market floor of $69/month.

4.4/5 across 869 reviews, verified directly on Trustpilot in August 2026. The distribution is the interesting part: about 80% of reviewers give five stars and about 12% give one star, with only ~8% landing anywhere in between. bmiMD's own marketing cites a 4.9-star average, which is higher than the independent Trustpilot figure — the 4.4 is the number to plan around.

A bimodal review pattern like bmiMD's — 80% five-star, 12% one-star, very little in the middle — usually means the core product works well when everything goes smoothly, and that the failure mode is operational rather than clinical. In bmiMD's case the recurring negative themes are billing and plan changes: people who want to alter or cancel a plan mid-term, and people surprised when the price moves off the 12-month rate. If you enroll, note the plan length you are agreeing to and how to change it before you pay.

bmiMD serves 48 states. Its GLP-1 program is not available in Louisiana or Mississippi, which is a common restriction among compounded providers because those states limit the compounding protocols involved. Consultation is included at no separate charge and shipping is free.

No — and that is true of every compounded GLP-1, not just bmiMD's. Compounded semaglutide and tirzepatide are prepared by compounding pharmacies from the same active ingredient as Ozempic, Wegovy, Mounjaro and Zepbound, but they are not FDA-approved finished products and have not been reviewed by the agency for that specific formulation. The FDA has published general concerns about unapproved GLP-1 drugs sold for weight loss. bmiMD does not offer a brand-name pathway, so if you specifically want an FDA-approved product you would need a provider that prescribes Wegovy or Zepbound.

It depends what you are optimising for. bmiMD is $119/month against a $69/month floor from Embody, so it is not the cheapest — you are paying roughly $600 more a year than the floor. What bmiMD offers instead is scale and a long operating record: 80,000-plus members and 869 independent reviews is far more public track record than most compounded providers have. If lowest price is the priority, the cheaper options are genuinely cheaper for the same molecule.